Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Feb 13, 2025Feb 14, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$116.85$298,908-1.80%
Feb 10, 2025Feb 12, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$118.39$116,020-0.71%
Jan 31, 2025Feb 04, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$152.87$235,577-1.11%
Jan 15, 2025Jan 17, 2025Gano Kyle
CEO
SellNeurocrine Biosciences IncNBIX$141.5$9M-32.44%
Feb 13, 2024Feb 15, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$132.9$179,674-0.99%
Feb 06, 2024Feb 09, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$139.16$359,041-1.89%
Jan 31, 2024Feb 03, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$140.7$216,813-1.16%
Jan 02, 2024Jan 04, 2024Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$131.47$10M-36.54%
Aug 21, 2023Aug 24, 2023Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$107.41$228,993-1.61%
Feb 06, 2023Feb 09, 2023Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$102.8$2M-11.72%
Jan 31, 2023Feb 02, 2023Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$109.99$169,486-1.35%
Feb 07, 2022Feb 09, 2022Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$80.61$554,628-5.83%
Jan 05, 2022Jan 07, 2022Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$85.5$2M-21.21%
Feb 05, 2021Feb 10, 2021Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$115.65$736,702-5.73%
Nov 12, 2020Nov 16, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$90.73$204,770-2.25%
Aug 05, 2020Aug 07, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$118.87$268,286-2.30%
Apr 24, 2020Apr 29, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$99.47$192,377-2.02%
Feb 07, 2020Feb 12, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$103.33$167,710-1.73%
Feb 05, 2020Feb 07, 2020Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$102.7$481,675-4.93%
Feb 06, 2019Feb 08, 2019Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$83.56$63,673-0.88%
Feb 04, 2019Feb 06, 2019Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$88.12$335,668-4.30%
Aug 01, 2018Aug 03, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$115$3M-26.41%
Mar 05, 2018Mar 07, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$90$2M-23.10%
Feb 05, 2018Feb 07, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$83.05$169,914-2.51%
Jan 16, 2018Jan 18, 2018Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$79.05$128,460-2.12%
Nov 02, 2017Nov 06, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$71.05$2M-25.31%
Sep 06, 2017Oct 03, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$60$1M-21.78%
Sep 06, 2017Sep 08, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$60$276,420-5.92%
May 01, 2017May 03, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$54$810,000-17.00%
Apr 12, 2017Apr 13, 2017Gano Kyle
Chief Business Development Off
SellNeurocrine Biosciences IncNBIX$50.42$658,774-15.14%